JFHG plans to expand 1000 tons of 2,6-Difluorobenzamide and 3000 tons of 1,4-Dicyanobenzene production lines
Recently, Hubei JFHG’s renovation and upgrading project phase II EIA acceptance was published. JFHG will invest ¥80 million in 2020 to build the "JF Industrial Enterprise Reconstruction and Upgrading Project" in the existing factory. After the completion of the project, the annual output of the project will be 2000 tons of Pseudourea, 2000 tons of TEMED, 1000 tons of Amide acetal, 1500 tons of Dimethyl chloroacetal and 3000 tons of 2-Chlorobenzonitrile.
On January 23, 2021, the project obtained the environmental assessment approval document (No.10 [2021]) from Jingmen Bureau of Ecological Environment.
Up to now, the project has completed the construction of two product lines of Amide acetal and 2-Chlorobenzonitrile, and has been put into trial production, and is now preparing for environmental acceptance. The construction unit plans to cancel the construction of the remaining three products of Pseudourea, TEMED and Dimethyl chloroacetal. In order to further utilize the remaining open space in the factory, the construction unit plans to invest 11 million yuan to construct the "JF Chemical Enterprise Reconstruction and Upgrading Project Phase II" in the existing factory. No new land will be added to the project. The project will construct three production lines with an annual output of 3,000 tons of 1,4-Dicyanobenzene, 1,000 tons of 2,6-Difluorobenzamide and 500 tons of 4-(trifluoromethyl)nicotinicacid after completion.
Founded in 2009, Hubei JFHG was a professional enterprise engaged in the development and production of fluorine chemical products.
2026-08-31
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Wanhua Chemical’s “Tale of Two Cities”: 850,000 Tonnes Isn’t Capacity—It’s a Declaration of War
-
Lilly Bets US$3 Billion on China While Simultaneously Cracking Down on the Gray Market for Weight-Loss Drugs
-
From LANXESS’s 50% to Tire Makers’ 5%: The Rubber Industry Chain Is Experiencing a “Decreasing-Cost Transmission”
-
Due to Supply Chain Disruptions, A Major MDI/TDI Facility in the Middle East has Suddenly Shut Down!
-
Henkel to Acquire Olaplex in $1.4 Billion Deal
-
Wanhua Chemical's Fujian 800,000 t/y MDI Plant Undergoes Scheduled Maintenance
-
Henkel Plans to Acquire Swiss Adhesive Specialist ATP Adhesive Systems, Expanding Its Sustainable Tape Portfolio
-
“The Agency Revolution”: BASF Breaks Into Dongfeng Liuzhou’s Supply Chain
-
Syensqo Launches AI-Developed Coffee Peptide for Scalp Care
-
“Strategic Amputation” or “Phoenix Rebirth”? AkzoNobel’s Global Retreat and a $25 Billion Gamble
Recommend Reading
-
BASF Commits to Safeguarding Jobs at the Ludwigshafen Site Through 2028 with Multi-Billion-Euro Investments
-
The Cost of 2,000 Jobs: How ExxonMobil Uses Layoffs to Announce a Global Chemical Map Reshuffle
-
Covestro Minority Shareholder Squeeze-Out Price Set at €59.46 per Share
-
BASF Raises European Amines by Up to 30% and LANXESS Raises Inorganic Pigments by Up to 20%
-
BASF’s €8.7 Billion Zhanjiang Verbund Site Fully Operational
-
“全球展会数据”功能上线公告 Announcement on the Launch of the “Global Exhibition Data” Function
-
Double Negative Impact on Costs and Demand—Polyester Staple Fiber Prices Shift Lower in May
-
Both Cost and Demand Weaken, PTA Prices Fluctuate and Decline in May
-
In May, China's acetone market shows weak supply and demand, leading to a downward trend
-
Polyethylene Market Continues to Show Weakness